MannKind Corporation's INHALE-3 Study Demonstrates Superiority of Inhaled Insulin Over Traditional Care in Type 1 Diabetes
Jun 23, 2024
MNKD Equities
MannKind Corporation Schedules Conference Call to Discuss Q4 and Full Year 2023 Financial Results
Feb 21, 2024